Craig Ackerman, partner in the Alexander Group and lead of its medical device practice, discusses how events from the past few years have shaped the current market.
Craig Ackerman
Advertisement
Articles by Craig Ackerman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
2
FDA Announces New Plausible Mechanism Pathway
3
Roundup: Ovid Therapeutics and Metagenomi Announce 2025 Third Quarter Results and Leadership Updates
4
WeightWatchers to Offer Novo Nordisk’s Oral Wegovy, if Approved Next Year
5
